AT301993T
Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
63 members in 8 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 21052088 | United States of America | A |
Members63
| Document | Office | Kind | |
|---|---|---|---|
| EP0270349A2 | European Patent Office (EPO) | A2 | |
| JPS63211225A | Japan | A | |
| EP0349224A2 | European Patent Office (EPO) | A2 | |
| JPH02117647A | Japan | A | |
| EP0270349A3 | European Patent Office (EPO) | A3 | |
| EP0349224A3 | European Patent Office (EPO) | A3 | |
| US5091576A | United States of America | A | |
| CA1305425C | Canada | C | |
| EP0536853A2 | European Patent Office (EPO) | A2 | |
| EP0536853A3 | European Patent Office (EPO) | A3 | |
| EP0270349B1 | European Patent Office (EPO) | B1 | |
| AT92466T | Austria | T | |
| ATE92466T1 | Austria | T1 | |
| DE3786896D1 | Germany | D1 | |
| DE3786896T2 | Germany | T2 | |
| JPH0653661B2 | Japan | B2 | |
| US5342945A | United States of America | A | |
| ES2059398T3 | Spain | T3 | |
| US5393757A | United States of America | A | |
| JPH07252193A | Japan | A | |
| US5455277A | United States of America | A | |
| US5462970A | United States of America | A | |
| EP0536853B1 | European Patent Office (EPO) | B1 | |
| AT136021T | Austria | T | |
| ATE136021T1 | Austria | T1 | |
| DE3751764D1 | Germany | D1 | |
| ES2088091T3 | Spain | T3 | |
| GR3020409T3 | Greece | T3 | |
| DE3751764T2 | Germany | T2 | |
| US5656671A | United States of America | A | |
| US5677351A | United States of America | A | |
| US5677352A | United States of America | A | |
| US5679682A | United States of America | A | |
| US5681837A | United States of America | A | |
| JP2673136B2 | Japan | B2 | |
| JP2748333B2 | Japan | B2 | |
| JPH10168067A | Japan | A | |
| US5827894A | United States of America | A | |
| US5866613A | United States of America | A | |
| US5886050A | United States of America | A | |
| JP2945360B2 | Japan | B2 | |
| CA1340773C | Canada | C | |
| US6034139A | United States of America | A | |
| US5866613B1 | United States of America | B1 | |
| US6147262A | United States of America | A | |
| US6184232B1 | United States of America | B1 | |
| US6262125B1 | United States of America | B1 | |
| US6342534B1 | United States of America | B1 | |
| US6362232B1 | United States of America | B1 | |
| US2002049256A1 | United States of America | A1 | |
| US2002094990A1 | United States of America | A1 | |
| US6455591B1 | United States of America | B1 | |
| US2002143068A1 | United States of America | A1 | |
| US6472426B2 | United States of America | B2 | |
| US2003100615A1 | United States of America | A1 | |
| USRE38417E | United States of America | E | |
| EP0349224B1 | European Patent Office (EPO) | B1 | |
| AT301993TThis record | Austria | T | |
| ATE301993T1 | Austria | T1 | |
| DE68929539D1 | Germany | D1 | |
| ES2244953T3 | Spain | T3 | |
| DE68929539T2 | Germany | T2 | |
| US7094808B2 | United States of America | B2 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 89306425
Titles2
- German
- ANTINEOPLASTISCHE, ANTIVIRALE ODER ANTIRETROVIRALE SPERMINDERIVATE
- English
- ANTINEOPLASTIC, ANTIVIRAL OR ANTIRETROVIRAL DERIVED DERIVATIVES
Classification
- CPC, 18
- C07D239/04
- A01N33/04
- A01N43/54
- A61K31/13
- A61K31/131
- A61K31/135
- A61K31/505
- A61K31/506
- A61K31/785
- A61P17/00
- C07C209/08
- A61P31/00
- C07C209/62
- A61P31/04
- C07C211/14
- A61P31/12
- A61P33/06
- A61P35/00
- IPC, 21
- A01N33 04
- A01N33 12
- A01N43 54
- A61K31 00
- A61K31 13
- A61K31 131
- A61K31 135
- A61K31 505
- A61K31 506
- A61K31 785
- A61P17 00
- A61P31 00
- A61P31 04
- A61P31 12
- A61P35 00
- C07C209 08
- C07C209 62
- C07C211 14
- C07C211 27
- C07C211 53
- C07D239 04